- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Shionogi & Co., Ltd. Profit Climbs In Full Year | 301 | AFX News | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. (SGIOF) revealed earnings for its full year that Increased, from last yearThe company's bottom line totaled JPY205.159 billion, or JPY241.04 per share.... ► Artikel lesen | |
| 21.04. | Shionogi starts phase 2 clinical trial for Pompe Disease | 5 | PMLiVE | ||
| 09.04. | Shionogi secures $482m BARDA contract to tackle AMR crisis | 3 | Pharmaceutical Technology | ||
| SHIONOGI & CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 08.04. | Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant | 3 | FiercePharma | ||
| 07.04. | Shionogi USA: ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja/Fetcroja (cefiderocol) in MBL-Producing Enterobacterales Infections | 313 | Business Wire | Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase... ► Artikel lesen | |
| 03.04. | Shionogi: $2.5 Billion Acquisition Of RADICAVA Establishes Rare Disease Platform | 9 | pulse2.com | ||
| 01.04. | ViiV Healthcare: Pfizer steigt aus, Shionogi erhöht Anteil | 27 | Investing.com Deutsch | ||
| 01.04. | Shionogi completes purchase of Pfizer stake in GSK's ViiV Healthcare | 9 | Alliance News | ||
| 24.03. | Shionogi pays Apnimed $100M for joint venture to awaken sleep disorder dream | 2 | FierceBiotech | ||
| 10.02. | Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd. | 532 | PR Newswire | BELFAST, Northern Ireland, Feb. 10, 2026 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and... ► Artikel lesen | |
| 02.02. | Shionogi & Co. GAAP EPS of ¥188.00, revenue of ¥500B | 8 | Seeking Alpha | ||
| 30.01. | Shionogi & Co., Ltd. Reports Rise In Nine Months Profit | 505 | AFX News | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. (SGIOF) reported earnings for its nine months that Increased, from last yearThe company's bottom line came in at JPY158.225 billion, or JPY185.91 per share.... ► Artikel lesen | |
| 25.01. | Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership | 25 | Insider Monkey | ||
| 20.01. | Pfizer exits GSK majority-owned ViiV Healthcare; Shionogi raises stake | 24 | Seeking Alpha | ||
| 20.01. | Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up | 4 | Pharmaceutical Technology | ||
| 20.01. | Pfizer sells its stake in GSK's ViiV for $1.9B, with Shionogi upping its ante in the HIV-focused company | 21 | FiercePharma | ||
| 20.01. | Shionogi stockt Anteil an ViiV Healthcare auf - Pfizer steigt aus | 28 | Investing.com Deutsch | ||
| 22.12.25 | ALS med Radicava to change hands as Shionogi inks $2.5B buyout | 3 | FiercePharma | ||
| 04.12.25 | Pfizer, GSK, Shionogi sponsor London run of musical about antimicrobial resistance | 9 | FiercePharma | ||
| 30.10.25 | Shionogi Announces Corporate Reorganization Following Japan Tobacco Pharma Merger | 1.043 | AFX News | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. Thursday announced it will implement a corporate reorganization and several personnel reassignments, effective December 1, 2025, in line with the upcoming... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 6,970 | +0,58 % | Trulieve Cannabis Corp.: Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation | First quarter revenue of $287 million, with 59% gross margin
Positive net income of $2 million and Adjusted EBITDA of $100 million*
Rescheduling of medical... ► Artikel lesen | |
| WEST PHARMACEUTICAL SERVICES | 265,90 | +0,04 % | Investors Await Damage Assessment After West Pharmaceutical Cyberattack | ||
| SHIONOGI | 16,015 | +5,47 % | Shionogi & Co., Ltd. Profit Climbs In Full Year | TOKYO (dpa-AFX) - Shionogi & Co., Ltd. (SGIOF) revealed earnings for its full year that Increased, from last yearThe company's bottom line totaled JPY205.159 billion, or JPY241.04 per share.... ► Artikel lesen | |
| KALA BIO | 0,067 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.05.2026 | Das Instrument ARRD LU1598757687 ARCELORMITTAL S.A. NOUV. EQUITY wird cum Kapitalmassnahme gehandelt am 11.05.2026 und ex Kapitalmassnahme am 12.05.2026 The instrument ARRD LU1598757687 ARCELORMITTAL... ► Artikel lesen | |
| CHARLOTTES WEB | 0,400 | +4,71 % | MMJ International Holdings: EU Regulators Say Charlotte's Web Hemp CBD Safety "Cannot Be Established" - So Why Is It Entering Medicare? | "As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, and Patient Protections" stated Duane Boise CEO MMJ International Holdings.... ► Artikel lesen | |
| BEXIMCO PHARMACEUTICALS | 0,414 | 0,00 % | Beximco Pharma: Gerichtsanhörung auf nach April verschoben | ||
| MIRUM PHARMACEUTICALS | 88,46 | -2,81 % | Mirum Pharmaceuticals prices $600M senior notes | ||
| LUYE PHARMA | 0,262 | -2,24 % | LUYE PHARMA (02186): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | ||
| PERCHERON THERAPEUTICS | 0,003 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2026 | Das Instrument 5RR CA7502321002 RADIAL RESEARCH CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2026 und ex Kapitalmassnahme am 19.03.2026 The instrument 5RR CA7502321002 RADIAL RESEARCH CORP.... ► Artikel lesen | |
| AYURCANN | 0,001 | 0,00 % | CSE Bulletin: Suspensions - Planet Green Metals Inc., Ayurcann Holdings Corp. | Le 9 mars/March 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| KALBE FARMA | 0,044 | 0,00 % | KLBF profit rises 13% in 2025, prepares IDR 500 billion buyback: Strong export lifts KLBF's net profit 13% to ... | ||
| AVANT BRANDS | 0,360 | 0,00 % | Avant Brands Inc.: Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders | KELOWNA, BC / ACCESS Newswire / May 4, 2026 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and special... ► Artikel lesen | |
| EVEREST MEDICINES | 3,280 | -5,75 % | Everest Medicines Limited: Everest Medicines Announces Positive First-in-Human Data for Personalized mRNA Cancer Vaccine EVM16 at AACR 2026 | - Demonstrating a Favorable Safety Profile, Robust Immunogenicity, and Promising Preliminary EfficacyHONG KONG, Apr 22, 2026 - (ACN Newswire) - Apr 20, Everest Medicines announced that the first-in-human... ► Artikel lesen | |
| KOBAYASHI PHARMACEUTICAL | 30,600 | 0,00 % | Kobayashi Pharmaceutical Co., Ltd. Reveals Retreat In Q1 Bottom Line | ||
| MERCK KGAA | 121,95 | +7,92 % | DAX-Check LIVE: Auto1, Brenntag, E.on, Merck, RWE, SFC Energy, SMA Solar, Verbio im Fokus | Die festgefahrene Lage im Nahen Osten hat den deutschen Aktienmarkt weiter belastet. Je länger der Konflikt andauert, desto größer werden die Sorgen vor wirtschaftlichen Folgen. Steigende Ölpreise und... ► Artikel lesen |
SHIONOGI & CO LTD ADR gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 8,600 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHIONOGI & CO LTD ADR finden Sie auf Wallstreet Online.